FABP4 and coronary artery disorder: Furthermore, the expression of FABP4 in adipocytes has been positively associated with mortality [21], incident diabetes mellitus [22], greater coronary plaque burden [23], coronary artery disease (CAD) [24], and heart failure (HF) [25].